Cargando…
Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation
Lupus is a chronic, systemic inflammatory condition in which eicosanoids, cytokines, nitric oxide (NO), a deranged immune system, and genetics play a significant role. Our studies revealed that an imbalance in the pro- and antioxidants and NO and an alteration in the metabolism of essential fatty ac...
Autor principal: | Das, Undurti N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218729/ https://www.ncbi.nlm.nih.gov/pubmed/22096364 http://dx.doi.org/10.2147/JIR.S9425 |
Ejemplares similares
-
Current Insights Into The Management Of Discoid Lupus Erythematosus
por: Company-Quiroga, Jaime, et al.
Publicado: (2019) -
Current Knowledge of the Molecular Pathogenesis of Cutaneous Lupus Erythematosus
por: Miyagawa, Fumi
Publicado: (2023) -
Molecular signatures in systemic lupus erythematosus: distinction between disease flare and infection
por: Mackay, Meggan, et al.
Publicado: (2016) -
Emerging Therapies in Cutaneous Lupus Erythematosus
por: Sprow, Grant, et al.
Publicado: (2022) -
Lipoxins as biomarkers of lupus and other inflammatory conditions
por: Das, Undurti N
Publicado: (2011)